Repligen (NASDAQ: RGEN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Repligen (NASDAQ: RGEN) through any online brokerage.
The latest price target for Repligen (NASDAQ: RGEN) was reported by Keybanc on Thursday, April 28, 2022. The analyst firm set a price target for 245.00 expecting RGEN to rise to within 12 months (a possible 45.44% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Repligen (NASDAQ: RGEN) is $168.45 last updated Today at July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Repligen.
Repligen’s Q2 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for Repligen.
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.